Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

NCT06731933 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: BVEC

Sponsor

Stanford University

Collaborators

[object Object]